These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Restarting clozapine: a case report. Barrons E, Johnson E, Nynkowski P. Psychiatr Serv; 1996 Jan; 47(1):92. PubMed ID: 8925356 [No Abstract] [Full Text] [Related]
4. Failure of rechallenge clozapine after agranulocytosis: A case report. Roméo B, Petillion A, Martelli C, Benyamina A. Encephale; 2019 Nov; 45(5):449-450. PubMed ID: 30878138 [No Abstract] [Full Text] [Related]
5. Combination of clozapine and aripiprazole: a promising approach in treatment-resistant schizophrenia. Ziegenbein M, Sieberer M, Calliess IT, Kropp S. Aust N Z J Psychiatry; 2005 Sep; 39(9):840-1. PubMed ID: 16168043 [No Abstract] [Full Text] [Related]
6. Immediate recurrence of psychotic symptoms after discontinuation of clozapine: a case report. Tanríverdi N, Yazící KM. Biol Psychiatry; 1996 May 01; 39(9):814-5. PubMed ID: 8731523 [No Abstract] [Full Text] [Related]
7. Late-onset agranulocytosis in a patient treated with clozapine and lamotrigine. Tourian L, Margolese HC. J Clin Psychopharmacol; 2011 Oct 01; 31(5):665-7. PubMed ID: 21881454 [No Abstract] [Full Text] [Related]
8. Management of clozapine-induced obsessive-compulsive symptoms in a man with schizophrenia. Zink M, Knopf U, Kuwilsky A. Aust N Z J Psychiatry; 2007 Mar 01; 41(3):293-4. PubMed ID: 17464712 [No Abstract] [Full Text] [Related]
12. Clozapine-induced eosinopenia correlates with high drug serum levels: A case report. Compagni C, Salvi V, Corulli M, Rosso R, Gramaglia C. Asian J Psychiatr; 2019 Jun 01; 43():83-84. PubMed ID: 31100604 [No Abstract] [Full Text] [Related]
13. Clozapine and ziprasidone: a useful combination in patients with treatment-resistant schizophrenia. Ziegenbein M, Calliess IT. J Neuropsychiatry Clin Neurosci; 2006 Jun 01; 18(2):246-7. PubMed ID: 16720806 [No Abstract] [Full Text] [Related]
15. Successful Use of Single Doses of Granulocyte-Colony Stimulating Factor (G-CSF) in the Treatment of Late-Onset Agranulocytosis Associated With Clozapine in a Patient With Treatment-Resistant Schizophrenia: A Case Report. Comacchio C, Dusi N, Lasalvia A. J Clin Psychopharmacol; 2016 Apr 01; 36(2):173-4. PubMed ID: 26859277 [No Abstract] [Full Text] [Related]
16. Late-onset clozapine-induced agranulocytosis in a patient with comorbid multiple sclerosis. Raveendranathan D, Sharma E, Venkatasubramanian G, Rao MG, Varambally S, Gangadhar BN. Gen Hosp Psychiatry; 2013 Apr 01; 35(5):574.e5-6. PubMed ID: 22902258 [Abstract] [Full Text] [Related]
17. [Ziprasidone-augmentation of clozapine]. Zink M, Mase E, Dressing H. Psychiatr Prax; 2004 Jul 01; 31(5):259-61. PubMed ID: 15243877 [Abstract] [Full Text] [Related]
18. Worsening of psychosis with clozapine and selective serotonin reuptake inhibitor combination: two case reports. Chong SA, Tan CH, Lee HS. J Clin Psychopharmacol; 1997 Feb 01; 17(1):68-9. PubMed ID: 9004072 [No Abstract] [Full Text] [Related]
19. Clozapine-induced agranulocytosis in Japan: Changes in leukocyte/neutrophil counts before and after discontinuation of clozapine. Matsui K, Ishibashi M, Kawano M, Oshibuchi H, Ishigooka J, Nishimura K, Inada K. Hum Psychopharmacol; 2020 Jul 01; 35(4):e2739. PubMed ID: 32420645 [Abstract] [Full Text] [Related]
20. Very high-dose clozapine and electroconvulsive therapy combination treatment in a patient with schizophrenia. Keller S, Drexler H, Lichtenberg P. J ECT; 2009 Dec 01; 25(4):280-1. PubMed ID: 19440159 [Abstract] [Full Text] [Related] Page: [Next] [New Search]